Tiziana Life Sciences Ltd

TLSA·NasdaqCM
Compare
1.0900−0.1000 (−8.40%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.1900
Open1.2000
Day range1.06991.2000
52-week range0.76002.2000
Off day high−9.17%
Off 52-week high−50.45%
Volume567.64K
Avg. volume (3M)754.20K
Market cap138.71M
EPS (TTM)-0.1600
Forward P/E-6.06
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding127.26M
Short interest—
Earnings dateJun 23, 2025 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
TLSA ZURA IMUX CHRS COYA HURA
Market cap 138.71M 383.32M 108.47M 159.14M 112.83M 121.08M
P/E (TTM) — — — — — —
Forward P/E -6.1 -5.8 -3.3 -1.6 -2.6 -3.1
Price/book — 1.9 0.9 2.6 2.6 6.6
Dividend yield — — — — — —
1-year change −44.13% +3.63% −8.49% −38.15% −18.32% −19.34%
Today −8.40% 0.00% −2.93% −3.74% −2.83% −3.06%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All TLSA news ›
Proactiveinvestors NA·Positive

Market movers: HPE, Boeing, Salesforce, Tiziana Life Sciences...

MongoDB Inc (NASDAQ:MDB) raised its long-term growth targets at its investor day, with Bank of America saying the event was a net positive and maintaining its Buy rating on the stock. For fiscal 2028 to 2030, the database company now…

Pluang·

Tiziana Life Sciences seeks FDA orphan drug sta...

Tiziana Life Sciences has applied to the US FDA for orphan drug designation for its intranasal foralumab to treat multiple system atrophy (MSA), a rare and rapidly progressing neurodegenerative disorder with no approved disease-modifying…

From articles in the 4Search news index.

In the news

6mentions in 30 days
6with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.